Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor
NCT00921336
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
KW-2450
Sponsor
Kyowa Kirin Co., Ltd.
Collaborators
[object Object]